Monoclonal antibodies to Mycobacterium tuberculosis CDC 1551 reveal subcellular localization of MPT51

Tuberculosis

Volumn 87, Issue 6, 2007, Pages 489-497

  Al Sayyed, Ban ^a   Piperdi, Sajida ^a   Yuan, Xinni ^a   Li, Anping ^a   Besra, Gurdyal S ^b   Jacobs Jr , William R ^a   Casadevall, Arturo ^a   Glatman Freedman, Aharona ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Monoclonal antibodies; MPT51; Mycobacterium tuberculosis

Indexed keywords

BACTERIAL PROTEIN; IMMUNOGLOBULIN G1 ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 16A1; MONOCLONAL ANTIBODY 16A6; PROTEIN MPT51; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BACTERIAL STRAIN; CELL WALL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSOL; IMMUNOPRECIPITATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, BACTERIAL; BACTERIAL ADHESION; BACTERIAL PROTEINS; CYTOSOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYBRIDOMAS; MICE; MICE, INBRED BALB C; MICROSCOPY, IMMUNOELECTRON; MYCOBACTERIUM TUBERCULOSIS;

EID: 35348872454     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tube.2007.07.005     Document Type: Article

References (38)

1. Glatman-Freedman A., Mednick A.J., Lendvai N., and Casadevall A. Clearance and organ distribution of Mycobacterium tuberculosis lipoarabinomannan (LAM) in the presence and absence of LAM-binding IgM. Infect Immun 68 (2000) 335-341
2. Glatman-Freedman A. Advances in antibody-mediated immunity against Mycobacterium tuberculosis: implications for a novel vaccine strategy. FEMS Immunol Med Microbiol 39 (2003) 9-16
3. Teitelbaum R., Glatman-Freedman A., Chen B., Robbins J.B., Unanue E., Casadevall A., et al. A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival. Proc Natl Acad Sci USA 95 (1998) 15688-15693
4. Chambers M.A., Gavier-Widen D., and Hewinson R.G. Antibody bound to the surface antigen MPB83 of Mycobacterium bovis enhances survival against high dose and low dose challenge. FEMS Immunol Med Microbiol 93-100 (2004)
5. Hamasur B., Haile M., Pawlowski A., Schroder U., Kallenius G., and Svenson S.B. A mycobacterial lipoarabinomannan specific monoclonal antibody and its F(ab′)2 fragment prolong survival of mice infected with Mycobacterium tuberculosis. Clin Exp Immunol 138 (2004) 30-38
6. Pethe K., Alonso S., Blet F., Delogu G., Brennan M.J., Locht C., et al. The heparine-binding haemaglutinin of M. tuberculosis is required for extrapulmonary dissemnation. Nature 412 (2001) 190-194
7. Williams A., Reljic R., Naylor I., Clark S.O., Falero-Diaz G., Singh M., et al. Passive protection with immunoglobulin A antibodies against tuberculous early infection of the lungs. Immunology 111 (2004) 328-333
8. Glatman-Freedman A. The role of antibody-mediated immunity in defense against Mycobacterium tuberculosis: advances toward a novel vaccine strategy. Tuberculosis 86 (2006) 191-197
9. Daffe M., and Draper P. The envelope layers of mycobacteria with reference to their pathogenicity. Adv Microb Physiol 39 (1998) 131-203
10. Ortalo-Magne A., Dupont M.-A., Lemassu A., anderson A.B., Gounon P., and Daffe M. Molecular composition of the outermost capsular material of the tubercle bacillus. Microbiology 141 (1995) 1609-1620
11. Ortalo-Magne A., Lemassu A., Laneelle M.A., Bardou F., Silve G., Gounon P., et al. Identification of the surface-exposed lipids on the cell envelope of Mycobacterium tuberculosis and other mycobacterial species. J Bacteriol 178 (1996) 456-461
12. Glatman-Freedman A., Casadevall A., Dai Z., Jacobs Jr. W.R., Li A., Morris S.L., et al. Antigenic evidence of prevalence and diversity of Mycobacterium tuberculosis arabinomannan. J Clin Microbiol 42 (2004) 3225-3231
13. Sambandamurthy V.K., Derrick S.C., Hsu T., Chen B., Larsen M.H., Jalapathy K.V., et al. Mycobacterium tuberculosis DeltaRD1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis. Vaccine 24 (2006) 6309-6320
14. Glatman-Freedman A., Martin J.M., Riska P.F., Bloom B.R., and Casadevall A. Monoclonal antibodies to surface antigens of Mycobacterium tuberculosis and their use in a modified enzyme-linked immunosorbent spot assay for detection of mycobacteria. J Clin Microbiol 34 (1996) 2795-2802
15. Schwebach J.R., Glatman-Freedman A., Gunter-Cummins L., Dai Z., Robbins J.R., Schneerson R., et al. Glucan is a component of the Mycobacterium tuberculosis surface that is expressed in vitro and in vivo. Infect Immune 70 (2002) 2566-2575
16. Wilson R.A., Maughan W.N., Kremer L., Besra G.S., and Futterer K. The structure of Mycobacterium tuberculosis MPT51 (FbpC1) defines a new family of non-catalytic α{plus 45 degree rule}β hydrolases. J Mol Biol 335 (2004) 519-530
17. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
18. Towbin H., Staehelin T., and Gordon J. Electophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets. Procedure and some applications. Pro Natl Acad Sci USA 76 (1979) 4350-4354
19. Mukherjee J., Scharff M.D., and Casadevall A. Protective murine monoclonal antibodies to Cryptococcus neoformans. Infect Immun 60 (1992) 4534-4541
20. Fernandez J., Gharahadaghi F., and Mische S.M. Routine identification of proteins from sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gels on polyvinyl difluoride membranes using matrix assisted laser desorption/ionization time of flight-mass spectrometry (MALDI-TOF-MS). Electrophoresis 19 (1998) 1036-1045
21. MS-Fit. Mass Spectrometry facility, University of California San Francisco, USA 〈http://prospector.ucsf.edu/ucsfhtml4.0/msfit.htm〉.
22. Mascot 〈http://www.matrixscience.com〉.
23. Navoa J.A.D., Laal S., Pirofski L., McLean G., Robbins J.B., Schneerson R., et al. Specificity and diversity of antibodies to Mycobacrerium tuberculosis arabinomannan. Clin Diagn Lab Immunol 10 (2003) 88-94
24. Anton V., Rouge P., and Daffe M. Identification of the sugars involved in mycobacterial cell aggregation. FEMS Microbiol Lett 144 (1996) 167-170
25. Hamasur B., Haile M., Pawlowski A., Schroder U., Williams A., Hatch G., et al. Mycobacterium tuberculosis arabinomannan-protein conjugates protect against tuberculosis. Vaccine 21 (2003) 4081-4093
26. Schwebach J.R., Casadevall A., Schneerson R., Dai Z., Wang X., Robbins J.B., et al. Expression of a Mycobacterium tuberculosis arabinomannan antigen in vitro and in vivo. Infect Immun 69 (2001) 5671-5678
27. Manca C., Tsenova L., Barry III C.E., Bergtold A., Freeman S., Haslett P.A.J., et al. Mycobacterium tuberculosis CDC 1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. J Immunol 162 (1999) 6740-6746
28. Nagai S., Wiker H.G., Harboe M., and Kinomoto M. Isolation and partial characterization of major protein antigens in the culture fluid of Mycobacterium tuberculosis. Infect Immun 59 (2001) 372-382
29. Ramalingam B., Baulard A.R., Locht C., Narayanan P.R., and Raja A. Cloning, expression, and purification of the 27 kDa (MPT51, Rv3803c) protein of Mycobacterium tuberculosis. Protein Express Purif 36 (2004) 53-60
30. Belisle J.T., Vissa V.D., Sievert T., Takayama K., Brennan P.J., and Besra G.S. Role of major antigen of Mycobacterium tuberculosis in cell wall biogenesis. Science 276 (1997) 1420-1422
31. Jackson M., Raynaud C., Laneelle M.A., Guilhot C., Laurent-Winter C., Ensergueix D., et al. Inactivation of the antigen 85C gene profoundly affects the mycolate content and alters the permeability of the Mycobacterium tuberculosis cell envelope. Mol Microbiol 31 (1999) 1573-1587
32. Naito M., Ohara N., Matsumoto S., and Yamada T. The novel fibronectin-binding motif and key residues of mycobacteria. J Biol Chem 273 (1998) 2905-2909
33. Ronning D.R., Klabunde T., Besta G.S., Vissa V.D., Belisle J.T., and Sacchettini J.C. Crystal structure of the secreted form of antigen 85C reveals potential targets for mycobacterial drugs and vaccines. Nat Struct Biol 7 (2000) 141-146
34. Ramalingam B., Uma Devi K.R., and Raja A. Isotype-specific anti-38 and 27 kDa (mpt51) response in pulmonary tuberculosis with human immunodeficiency virus coinfection. Scand J Infect Dis 35 (2003) 234-239
35. Singh K.K., Dong Y., Belisle J.T., Harder J., Arora V.K., and Laal S. Antigens of Mycobacterium tuberculosis recognized by antibodies during incipient, subclinical tuberculosis. Clin Diagn Lab Immunol 12 (2005) 354-358
36. Rosenkrands I., Weldingh K., Jacobsen S., Hansen C.V., Florio W., Gianetri I., et al. Mapping and identification of Mycobacterium tuberculosis proteins by two-dimentional gel electrophoresis, microsequencing and immunodetection. Electrophoresis 21 (2000) 935-948
37. Belisle J.T., Braunstein M., Rosenkrands I., and Andersen P. The proteonome of Mycobacterium tuberculosis. In: Cole S.T., Eisenach K.D., McMurray D.N., and Jacobs Jr. W.R. (Eds). The proteonome of Mycobacterium tuberculosis (2005), ASM Press, Washington, DC 235-260
38. Glossary. In: Janeway C.A., Travers P., Walport M., and Shlomchik M.J. (Eds). Immunobiology (2005), Garland Science, New York, London 753pp.